Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: Effects on primary bile acids in babies and mothers

Hepatology

Volumn 33, Issue 3, 2001, Pages 504-508

  Mazzella, Giuseppe ^a   Nicola, Rizzo ^b   Francesco, Azzaroli ^a   Patrizia, Simoni ^a   Luciano, Bovicelli ^b   Anna, Miracolo ^a   Giuliana, Simonazzi ^b   Antonio, Colecchia ^a   Giovanni, Nigro ^a   Constance, Mwangemi ^a   Davide, Festi ^c   Enrico, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CHOLIC ACID; URSILON 300; URSODEOXYCHOLIC ACID;

ADULT; AMNION FLUID; ARTICLE; BILIARY CIRRHOSIS; BLOOD PLACENTA BARRIER; CHOLESTASIS; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; HUMAN; LIVER FUNCTION TEST; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; UMBILICAL CORD; UMBILICAL CORD BLOOD;

EID: 17744364497     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22647     Document Type: Article

References (22)

1. Intrahepatic cholestasis of pregnancy
2. Management of intrahepatic cholestasis in pregnancy
3. Effects of Ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy
4. Ursodeoxycholic acid in intrahepatic choleslasis of pregnancy
5. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: A randomized, double-blind study controlled with placebo
6. Correction of maternal serum bile acid profile during ursodeoxycholic therapy in cholestasis of pregnancy
7. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment
8. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage
9. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group
10. Production of a high titer antibody to bile acids
11. Luminometric methods for bile acids
12. Effects of secondary bile acids on the intrauterine development in rats
13. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy
14. Amniotic fluid bile acid changes in the course of ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy
15. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta
16. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids
17. Hepatic 3-hydroxy-3methylglutarylcoenzime A reductase activity and biliary lipid composition in man: Relation to cholesterol gallstone disease and effect of cholic acid and chenodeoxycholic acid treatment
18. Ursodeoxyxholic acid treatment in cholesterol gallstone disease: Effects on hepatic 3-hydroxy-3methylglutaryl-coenzyme A reductase activity, biliary lipid composition and plasma lipid levels
19. Effect of ursodeoxycholic acid on ischemia/reperfusion injury in isolated rat heart
20. Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
21. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins
22. Serum bile acids in newborns and children